SCHD Is Down From Its All-Time High. Here's Why I'm Not Selling.

TNL Mediagene regains Nasdaq minimum bid price compliance

Blue Origin eyes 50 annual New Glenn launches in $330M Cape Canaveral expansion

Lilly wins EU backing for Foundayo weight-loss pill

Jefferies technical analyst finds an encouraging development in Thursday rebound, setting stage for rally into year-end